ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 564

Molecular Identification of a Ro-Specific Salivary IgA Repertoire with Unique Clonal Signatures in Primary Sjogren’s Syndrome

Jing Jing Wang1, Alexander Colella1, Tim Chataway2, R. Hal Scofield3 and Tom Gordon1,4, 1Immunology, Flinders University, Adelaide, Australia, 2Proteomic Facility, Flinders University, Adelaide, Australia, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Immunology, SA Pathology, Adelaide, Australia

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Sjogren's syndrome and autoantibodies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Sjögren's Syndrome Poster I: Translational Research

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Autoantibodies against 60-kD Ro (Ro60)/SSA have been detected in the saliva and serum of patients with primary Sjögren’s syndrome (SS) by routine methods that are unable to resolve molecular characteristics of interacting antibodies. Accordingly, it is unknown whether the parallel glandular and systemic anti-Ro60 responses derive from related or independent antibody repertoires. In the present study, we have identified a Ro60-specific salivary IgA repertoire by analysing immunoglobulin variable region (IGV) subfamily composition and mutational profiles of matched salivary and serum proteomes.

Methods: Anti-Ro60 autoantibodies were purified and sequenced from Ro-specific precipitins prepared by electrophoresing native Ro60 protein against whole saliva or serum collected from 9 patients with seropositive primary SS. Microgram amounts of precipitating anti-Ro60 Igs were separated by SDS-PAGE, and in-gel chymotrypsin digests performed on heavy (H) and light (L) chain bands. VH/VL and constant-region peptides were subjected to nano-high performance liquid chromatography-mass spectrometry (nHPLC-MS/MS) followed by combined de novo amino acid sequencing and database matching using Peaks 8.0 software utilising ImMunoGeneTics (IMGT) and Uniprot databases.

Results: High-resolution MS sequencing of purified salivary anti-Ro60 H- and L-chains revealed a common (9/9 patients) oligoclonal IgA Ro60 repertoire dominated by IGHV3-23 and IGKV3-20 subfamily expression. Paired serum anti-Ro60 proteomes expressed a more diversified IgG1 repertoire with expression of additional IGHV1 and IGHV3 families in the systemic compartment. IGHV3-23-encoded H-chains were present in matched saliva and serum samples but were distinct in terms of their patterns of somatic mutations, suggesting independent pathways of affinity maturation. Three of 9 patients showed a less abundant IgG1 salivary anti-Ro60 proteome that was similar to the paired serum proteome.

Conclusion: Proteomic profiling of salivary and serum anti-Ro60 autoantibodies in primary SS reveals a unique salivary IgA repertoire with specific V-region peptide profiles, consistent with a parallel yet distinct salivary gland pathway of somatically selected anti-Ro60 autoantibodies. The novel proteomic workflow reported herein will allow analysis of clonal turnover of mucosal and systemic autoantibody repertoires in early versus established disease and provide molecular biomarkers to assess responses to therapy in the glandular and peripheral compartments.


Disclosure: J. J. Wang, None; A. Colella, None; T. Chataway, None; R. H. Scofield, None; T. Gordon, None.

To cite this abstract in AMA style:

Wang JJ, Colella A, Chataway T, Scofield RH, Gordon T. Molecular Identification of a Ro-Specific Salivary IgA Repertoire with Unique Clonal Signatures in Primary Sjogren’s Syndrome [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/molecular-identification-of-a-ro-specific-salivary-iga-repertoire-with-unique-clonal-signatures-in-primary-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/molecular-identification-of-a-ro-specific-salivary-iga-repertoire-with-unique-clonal-signatures-in-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology